|
1
|
Pignon JP, Bourhis J, Domenge C and
Designé L: Chemotherapy added to locoregional treatment for head
and neck squamous-cell carcinoma: Three meta-analyses of updated
individual data. MACH-NC Collaborative Group Meta-Analysis of
Chemotherapy on Head and Neck Cancer. Lancet. 355:949–955. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Smith RV, Kotz T, Beitler JJ and Wadler S:
Long-term swallowing problems after organ preservation therapy with
concomitant radiation therapy and intravenous hydroxyurea: Initial
results. Arch Otolaryngol Head Neck Surg. 126:384–389. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cinelli M, Magnelli L and Chiarugi V:
Redundant down-regulation pathways for p53. Pharmacol Res.
37:83–85. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Osman I, Sherman E, Singh B, Venkatraman
E, Zelefsky M, Bosl G, Scher H, Shah J, Shaha A, Kraus D, et al:
Alteration of p53 pathway in squamous cell carcinoma of the head
and neck: Impact on treatment outcome in patients treated with
larynx preservation intent. J Clin Oncol. 20:2980–2987. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nam TK, Lee JH, Cho SH, Chung IJ, Ahn SJ,
Song JY, Yoon MS, Chung WK and Nah BS: Low hMLH1 expression prior
to definitive chemoradiotherapy predicts poor prognosis in
esophageal squamous cell carcinoma. Cancer Lett. 260:109–117. 2008.
View Article : Google Scholar
|
|
6
|
Li SW, Wang H, Liu ML, Zhang HB, Xiang YQ,
Lv X, Xia WX, Zeng MS, Mai HQ, Hong MH, et al: Positive effect of
high RKIP expression on reduced distant metastasis by chemotherapy
when combined with radiotherapy in locoregionally advanced
nasopharyngeal carcinoma: A prospective study. Med Oncol.
30:3222013. View Article : Google Scholar
|
|
7
|
Cheng SH, Jian JJ, Tsai SY, Chan KY, Yen
LK, Chu NM, Tan TD, Tsou MH and Huang AT: Prognostic features and
treatment outcome in locoregionally advanced nasopharyngeal
carcinoma following concurrent chemotherapy and radiotherapy. Int J
Radiat Oncol Biol Phys. 41:755–762. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen C, Chen S, Le QT, Chen J, Chen Z and
Li D, Zhou M and Li D: Prognostic model for distant metastasis in
locally advanced nasopharyngeal carcinoma after concurrent
chemoradiotherapy. Head Neck. 37:209–214. 2015. View Article : Google Scholar
|
|
9
|
Wang TL, Diaz LA Jr, Romans K, Bardelli A,
Saha S, Galizia G, Choti M, Donehower R, Parmigiani G, Shih IeM, et
al: Digital karyotyping identifies thymidylate synthase
amplification as a mechanism of resistance to 5-fluorouracil in
metastatic colorectal cancer patients. Proc Natl Acad Sci USA.
101:3089–3094. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van den Broek GB, Wreesmann VB, van den
Brekel MW, Rasch CR, Balm AJ and Rao PH: Genetic abnormalities
associated with chemoradiation resistance of head and neck squamous
cell carcinoma. Clin Cancer Res. 13:4386–4391. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Przybytkowski E, Aguilar-Mahecha A, Nabavi
S, Tonellato PJ and Basik M: Ultradense array CGH and discovery of
micro-copy number alterations and gene fusions in the cancer
genome. Methods Mol Biol. 973:15–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Joo YH, Park SW, Jung SH, Lee YS, Nam IC,
Cho KJ, Park JO, Chung YJ and Kim MS: Recurrent loss of the FHIT
gene and its impact on lymphatic metastasis in early oral squamous
cell carcinoma. Acta Otolaryngol. 133:992–999. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim JH, Hu HJ, Yim SH, Bae JS, Kim SY and
Chung YJ: CNVRuler: A copy number variation-based case-control
association analysis tool. Bioinformatics. 28:1790–1792. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jung SH, Yim SH, Hu HJ, Lee KH, Lee JH,
Sheen DH, Lim MK, Kim SY, Park SW, Kim SH, et al: Genome-wide copy
number variation analysis identifies deletion variants associated
with ankylosing spondylitis. Arthritis Rheumatol. 66:2103–2112.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
16
|
Oddone N, Morgan GJ, Palme CE, Perera L,
Shannon J, Wong E, Gebski V and Veness MJ: Metastatic cutaneous
squamous cell carcinoma of the head and neck: The
Immunosuppression, Treatment, Extranodal spread, and Margin status
(ITEM) prognostic score to predict outcome and the need to improve
survival. Cancer. 115:1883–1891. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bernaldo de Quirós S, Merlo A, Secades P,
Zambrano I, de Santa María IS, Ugidos N, Jantus-Lewintre E, Sirera
R, Suarez C and Chiara MD: Identification of TRPC6 as a possible
candidate target gene within an amplicon at 11q21-q22.2 for
migratory capacity in head and neck squamous cell carcinomas. BMC
Cancer. 13:1162013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi ZZ, Shang L, Jiang YY, Hao JJ, Zhang
Y, Zhang TT, Lin DC, Liu SG, Wang BS, Gong T, et al: Consistent and
differential genetic aberrations between esophageal dysplasia and
squamous cell carcinoma detected by array comparative genomic
hybridization. Clin Cancer Res. 19:5867–5878. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao Z, Meng X, Mu D, Sun X and Yu J:
Prognostic significance of epidermal growth factor receptor in
locally advanced esophageal squamous cell carcinoma for patients
receiving chemoradiotherapy. Oncol Lett. 7:1118–1122.
2014.PubMed/NCBI
|
|
20
|
Szabó B, Nelhubel GA, Kárpáti A, Kenessey
I, Jóri B, Székely C, Peták I, Lotz G, Hegedus Z, Hegedus B, et al:
Clinical significance of genetic alterations and expression of
epidermal growth factor receptor (EGFR) in head and neck squamous
cell carcinomas. Oral Oncol. 47:487–496. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chung CH, Ely K, McGavran L,
Varella-Garcia M, Parker J, Parker N, Jarrett C, Carter J, Murphy
BA, Netterville J, et al: Increased epidermal growth factor
receptor gene copy number is associated with poor prognosis in head
and neck squamous cell carcinomas. J Clin Oncol. 24:4170–4176.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wilson PM, Danenberg PV, Johnston PG, Lenz
HJ and Ladner RD: Standing the test of time: Targeting thymidylate
biosynthesis in cancer therapy. Nat Rev Clin Oncol. 11:282–298.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Johnston PG, Fisher ER, Rockette HE,
Fisher B, Wolmark N, Drake JC, Chabner BA and Allegra CJ: The role
of thymidylate synthase expression in prognosis and outcome of
adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol.
12:2640–2647. 1994.PubMed/NCBI
|
|
24
|
Murata S, Adachi M, Kioi M, Torigoe S,
Ijichi K, Hasegawa Y, Ogawa T, Bhayani MK, Lai SY, Mitsudo K, et
al: Etodolac improves 5-FU sensitivity of head and neck cancer
cells through inhibition of thymidylate synthase. Anticancer Res.
31:2893–2898. 2011.PubMed/NCBI
|
|
25
|
Yeh KH, Shun CT, Chen CL, Lin JT, Lee WJ,
Lee PH, Chen YC and Cheng AL: High expression of thymidylate
synthase is associated with the drug resistance of gastric
carcinoma to high dose 5-fluorouracil-based systemic chemotherapy.
Cancer. 82:1626–1631. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yasumatsu R, Nakashima T, Uryu H, Ayada T,
Wakasaki T, Kogo R, Masuda M, Fukushima M and Komune S:
Correlations between thymidylate synthase expression and
chemosensitivity to 5-fluorouracil, cell proliferation and clinical
outcome in head and neck squamous cell carcinoma. Chemotherapy.
55:36–41. 2009. View Article : Google Scholar
|
|
27
|
Sunwoo JB, Sun PC, Gupta VK, Schmidt AP,
El-Mofty S and Scholnick SB: Localization of a putative tumor
suppressor gene in the sub-telomeric region of chromosome 8p.
Oncogene. 18:2651–2655. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ishwad CS, Shuster M, Bockmühl U, Thakker
N, Shah P, Toomes C, Dixon M, Ferrell RE and Gollin SM: Frequent
allelic loss and homozygous deletion in chromosome band 8p23 in
oral cancer. Int J Cancer. 80:25–31. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Toomes C, Jackson A, Maguire K, Wood J,
Gollin S, Ishwad C, Paterson I, Prime S, Parkinson K, Bell S, et
al: The presence of multiple regions of homozygous deletion at the
CSMD1 locus in oral squamous cell carcinoma question the role of
CSMD1 in head and neck carcinogenesis. Genes Chromosomes Cancer.
37:132–140. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ma C, Quesnelle KM, Sparano A, Rao S, Park
MS, Cohen MA, Wang Y, Samanta M, Kumar MS, Aziz MU, et al:
Characterization CSMD1 in a large set of primary lung, head and
neck, breast and skin cancer tissues. Cancer Biol Ther. 8:907–916.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang R and Song C: Loss of CSMD1 or 2 may
contribute to the poor prognosis of colorectal cancer patients.
Tumour Biol. 35:4419–4423. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kamal M, Shaaban AM, Zhang L, Walker C,
Gray S, Thakker N, Toomes C, Speirs V and Bell SM: Loss of CSMD1
expression is associated with high tumour grade and poor survival
in invasive ductal breast carcinoma. Breast Cancer Res Treat.
121:555–563. 2010. View Article : Google Scholar
|
